Identification and Verification of Biomarker in Clear Cell Renal Cell Carcinoma via Bioinformatics and Neural Network

Bin Liu1, Yu Xiao2, Hao Li3

  • 1Department of Urinary Surgery, The Fourth Hospital of Hebei Medical University, No. 12 Jiankang Road, 050000, China.

Abstract

Insights

This study identified four key genes (AURKB, CCNA2, TPX2, and NCAPG) as potential biomarkers for clear cell renal cell carcinoma (ccRCC) progression. Their elevated expression correlates with advanced ccRCC stages and poorer patient survival.

Area of Science:

  • Oncology
  • Bioinformatics
  • Molecular Biology

Background:

  • Clear cell renal cell carcinoma (ccRCC) is the most prevalent kidney cancer subtype, yet its underlying molecular mechanisms remain unclear.
  • Identifying key molecular drivers is crucial for understanding ccRCC pathogenesis and developing targeted therapies.

Purpose of the Study:

  • To identify novel hub biomarkers associated with the occurrence and development of ccRCC.
  • To validate the diagnostic and prognostic potential of identified biomarkers using bioinformatics and experimental approaches.

Main Methods:

  • Utilized Gene Expression Omnibus (GEO) data to identify differentially expressed genes (DEGs) between ccRCC and normal tissues.
  • Constructed protein-protein interaction (PPI) networks to screen for hub genes using cytoHubba.
  • Validated hub gene expression in ccRCC and normal samples via RT-qPCR and constructed a neural network model.

Main Results:

  • Identified 251 DEGs and ten hub genes, with AURKB, CCNA2, TPX2, and NCAPG showing significant upregulation in ccRCC.
  • High expression of these four genes correlated with advanced pathological stages and reduced overall survival in ccRCC patients.
  • RT-qPCR and neural network analysis confirmed the expression patterns and inter-gene correlations of the identified hub genes.

Conclusions:

  • AURKB, CCNA2, TPX2, and NCAPG are strongly implicated in the occurrence and malignant progression of ccRCC.
  • These genes represent potential diagnostic and prognostic biomarkers for ccRCC.
  • Further research into these hub genes could elucidate ccRCC development and inform therapeutic strategies.

Related Concept Videos